CWC21178 - Vaccination Services

Tender description

The enhanced vaccination programme will consist of two elements: • Mobile and roving clinical vaccination provision offered across the city to priority cohorts including eligible cohorts who remain unvaccinated, Middle Layer Super Output priority areas (MSOA), businesses, university students and homelessness and new arrival providers. The roving and mobile model will enable the administration of Covid-19 vaccines at flexible locations outside of existing vaccination site provision to residents of Wolverhampton. The aim of roving and mobile provision is to improve access and maximise vaccine uptake in certain geographical areas, communities or among groups with low coverage. • An outreach and engagement programme consisting of a multipronged approach in order to drive uptake and will include the following themes: partnerships, access and communications. This will involve analysis and identification of the highest priority low uptake groups and further segmentation to understand the root causes of vaccine hesitancy and solutions to deliver successful interventions to drive uptake. Lot 1: The enhanced vaccination programme will consist of two elements: • Mobile and roving clinical vaccination provision offered across the city to priority cohorts including eligible cohorts who remain unvaccinated, Middle Layer Super Output priority areas (MSOA), businesses, university students and homelessness and new arrival providers. The roving and mobile model will enable the administration of Covid-19 vaccines at flexible locations outside of existing vaccination site provision to residents of Wolverhampton. The aim of roving and mobile provision is to improve access and maximise vaccine uptake in certain geographical areas, communities or among groups with low coverage. • An outreach and engagement programme consisting of a multipronged approach in order to drive uptake and will include the following themes: partnerships, access and communications. This will involve analysis and identification of the highest priority low uptake groups and further segmentation to understand the root causes of vaccine hesitancy and solutions to deliver successful interventions to drive uptake.